https://www.zacks.com/stock/news/2221192/itgr-or-ew-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2221192
Feb 05, 2024 - ITGR vs. EW: Which Stock Is the Better Value Option?
zc:-8354403655261042688
0
https://www.zacks.com/stock/news/2222672/microbot-medical-mbot-files-ide-to-start-human-clinical-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2222672
Feb 07, 2024 - Microbot Medical (MBOT) files an IDE with the FDA, approval of which will enable the company to proceed with its human clinical study in the United States.
zc:8142590005579817981
0
https://www.zacks.com/stock/news/2224203/fresenius-medical-fms-gets-fda-nod-for-new-hemodialysis-system?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2224203
Feb 09, 2024 - Fresenius Medical (FMS) receives an FDA nod for its new 5008X Hemodialysis System that aims to provide better dialysis therapy for kidney patients in the United States.
zc:6167810298944944788
0
https://www.zacks.com/stock/news/2225610/resmed-rmd-to-treat-sleep-apnea-with-new-aircurve-11-device?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2225610
Feb 13, 2024 - ResMed's (RMD) new AirCurve11 series incorporates myAir and AirView digital health apps to provide maximum comfort and support during therapy.
zc:-4229782709187664059
0
https://www.zacks.com/stock/news/2225550/globus-medical-gmed-expected-to-beat-earnings-estimates-can-the-stock-move-higher?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2225550
Feb 13, 2024 - Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-2594412416634273733
0
https://www.zacks.com/stock/news/2226830/edwards-ew-gains-from-balanced-core-growth-and-new-launches?cid=CS-ZC-FT-analyst_blog|zer_report_update-2226830
Feb 15, 2024 - Edwards (EW) is demonstrating the strong performance of the SAPIEN 3 Ultra valve in the United States, Europe and Rest of World.
zc:-4002913772354738278
0
https://www.zacks.com/stock/news/2226906/compared-to-estimates-integer-itgr-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2226906
Feb 15, 2024 - The headline numbers for Integer (ITGR) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:-1867058259631135587
0
https://www.zacks.com/stock/news/2227728/here-s-why-you-should-add-masimo-masi-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227728
Feb 19, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
zc:7755680708405352731
0
https://www.zacks.com/stock/news/2232440/why-integer-itgr-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2232440
Feb 27, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zc:375226197444117031
0
https://www.zacks.com/stock/news/2238036/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2238036
Mar 08, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zc:-7502261467775102040
0